Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original clinical research authored by leading international clinicians and researchers to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
As a hybrid journal, Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.
Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.
As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
Drugs & Therapy Perspectives provides concise, authoritative review articles to aid drug formulary and prescribing decisions. It is a digest of the latest drug knowledge covering the most important aspects of clinical therapeutics, including:Questions and answers on the clinical use of drugs.Comparisons of the features of various drugs, using differential feature tables.Current thinking on disease management.Step-by-step clinical decision-making, illustrated with patient care algorithms.First reports of serious adverse drug reactions.Clinically useful pharmacodynamics and pharmacokinetics.Developments in pharmacoeconomics and other research that have a bearing on clinical practice.All material is prepared by Adis editors and medical writers, unless otherwise noted. The preparation of material is not supported by any external funding. All review articles are subject to peer review by members of the journal's international editorial board and/or other experts.
Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.
Drugs in R&D is an international, peer reviewed, open access, online only journal, which provides timely information on emerging drug classes and new treatments for specific disorders in an ‘open access’ format for all to review. Original research and reviews from all phases of clinical development are included, with a strong link to clinical practice. Healthcare decision makers are thus provided with clinically applicable knowledge about the likely place in therapy of a drug.Journal issues comprise:· Original research on new drugs, including clinical trials:· New research on established drugs.· R&D Insight reports:Short communications and letters to the editor are welcomed and will be considered for publication. Reviews may also be considered. All manuscripts are subject to peer review by international experts.
Dynamic Games and Applications is devoted to the development of all classes of dynamic games, namely, differential games, discrete-time dynamic games, evolutionary games, repeated and stochastic games, and their applications in all fields, including:* biology:* computer science:* ecology:* economics:* engineering:* management science:* operations research:* political science:* psychology. DGAA seeks original research that makes significant methodological, conceptual, algorithmic, or empirical contributions to various disciplines. DGAA also considers work in static game theory and dynamic optimization provided that authors establish a clear, potential link to dynamic games. DGAA publishes regular papers, technical notes, survey articles, and case studies.All submissions should be original in nature. During the peer review process, to promote scientific honesty and high standards, submitted manuscripts go through one or more revision stages leading up to acceptance or rejection. Each paper is reviewed by at least two experts in the field.
Dysphagia is a multidisciplinary journal devoted to swallowing and its disorders. The journal's purpose is to provide an international source of information to physicians and other health professionals interested in this emerging field. Its scope includes all aspects of normal and dysphagic ingestion involving the mouth, pharynx, and esophagus. Accordingly, the journal will draw on expertise from a variety of disciplines including gastroenterology, neurology, otolaryngology, radiology, dentistry, rehabilitation medicine, speech pathology, nursing, dietetics, medical administration, and the basic biomedical sciences. The journal is intended to contribute to the development of this field by fostering communication between interested professionals, by setting forth existing knowledge, and by stimulating further research. Submission of contributions that advance the understanding of normal swallowing as well as those related to dysphagia, its diagnosis, and its clinical management, is encouraged. Dysphagia has be
Nuclear Medicine, Imaging / Radiology, Applied and Technical Physics, Computational Mathematics and Numerical Analysis, Engineering
EJNMMI Research is a peer-reviewed open access journal published under the brand SpringerOpen. It focuses on new basic, translational and clinical research in the field of nuclear medicine and molecular imaging.Regular features include original research articles, rapid communications on preliminary novel research, interesting case reports, editorials, and letters to the editor. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
ENGINEERING Chemical Engineering is a multidisciplinary journal highlighting advancements in chemical science and engineering.
ENGINEERING Energy, formerly known as Frontiers in Energy, is an international journal that presents frontiers, innovation, and interdisciplinary research in energy science and engineering.
ENGINEERING Environment is an international journal advancing and disseminating knowledge across environmental science and engineering disciplines.